Crestline Management, LP Wave Life Sciences Ltd. Transaction History
Crestline Management, LP
- $2.93 Billion
- Q4 2024
A detailed history of Crestline Management, LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Crestline Management, LP holds 158,336 shares of WVE stock, worth $1.76 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
158,336
Previous 135,260
17.06%
Holding current value
$1.76 Million
Previous $1.11 Million
76.56%
% of portfolio
0.07%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$203 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$107 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$91.9 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$75 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$74.7 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $966M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...